MS4A1 and neoplasm: By definition the diagnosis requires thatthe prolymphocytes exceed 55% of all lymphoid cells in the peripheral blood.1 Flow cytometry is used to distinguish B-PLL from similar neoplasms andusually demonstrates light chain restriction, bright surface immunoglobulin, and theexpression of B-cell antigens including CD20, CD22, FMC7, and CD79a.